Described are methods and compositions that inhibit IL-1 signalling for the treatment of acute inflammatory response to cell necrosis, and the attendant collateral tissue damage.

 
Web www.patentalert.com

< Cosmetic and reconstructive prostheses with a microencapsulated biologically compatible rupture indicator for sustained release and methods of detecting compromise of a prosthesis

< Oil-in-water capsule manufacture process and microcapsules produced by such process

> Composition for enzyme inhibition

> HGF beta chain variants
~ 00614